David Roberge

Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases

Paul W. Sperduto, Norbert Kased, David Roberge et al. · Journal of Clinical Oncology · 2011 · 1.4K citations · Full text

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial

Paul D. Brown, Karla V. Ballman, Jane H. Cerhan et al. · The Lancet Oncology · 2017 · 1.2K citations · Full text

Neuro-oncology, Health Sciences, Radiation Therapy +9

Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients

Paul W. Sperduto, Samuel T. Chao, Penny K. Sneed et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 975 citations

Neuro-oncology, Brain Metastases, Medicine +8

Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial

Paul D. Brown, S. Pugh, Nadia N. Laack et al. · Neuro-Oncology · 2013 · 921 citations · Full text

Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001

Paul D. Brown, Vinai Gondi, Stephanie L. Pugh et al. · Journal of Clinical Oncology · 2020 · 783 citations · Full text